EMID2 Activators
EMID2 Activators involve a group of chemicals that affect chromatin architecture and gene expression regulation, thereby enhancing the function of EMID2. The protein EMID2 is integral to the structural organization of chromatin, a complex of DNA and protein found in eukaryotic cells that packages the lengthy DNA into a more compact, manageable form. This compactness regulates DNA replication and gene expression, as the degree of packing can repress or permit access to certain genetic sequences. Chemicals such as JQ1, Trichostatin A, and SAHA (Vorinostat) inhibit proteins that modify chromatin structure, namely histone acetyltransferases and deacetylases. By altering the interaction ofhistones with DNA, these compounds can increase chromatin accessibility, enhancing the activity of EMID2 in the process of remodeling chromatin.
On the other hand, agents like 5-Aza-2'-deoxycytidine and RG108 inhibit DNA methyltransferases, leading to a decrease in DNA methylation. Hypomethylation of DNA can lead to a more open chromatin state, which may also enhance the functional activity of EMID2. Furthermore, compounds such as Methylstat, UNC0638, and Chaetocin inhibit various histone methyltransferases, leading to changes in histone methylation marks. These changes can alter the chromatin landscape, affecting the activity of EMID2 in terms of chromatin organization and gene expression regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 targets the bromodomain and extra-terminal (BET) family of proteins, inhibiting their interaction with acetylated lysines and affecting gene expression. EMID2, involved in chromatin remodeling, can be functionally enhanced when chromatin accessibility is modified by JQ1. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that leads to hyperacetylation of histones, affecting gene expression and chromatin structure. EMID2, associated with chromatin architecture, may experience enhanced activation due to changes in chromatin dynamics induced by Trichostatin A. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2'-deoxycytidine is a DNA methyltransferase inhibitor, leading to hypomethylation of DNA and altered gene expression. EMID2, which participates in chromatin organization, could have increased activity due to the resulting changes in the chromatin landscape. | ||||||
Methylstat | 1310877-95-2 | sc-507374 | 10 mg | $480.00 | ||
Methylstat is a Jumonji C domain-containing histone demethylase inhibitor, which leads to increased methylation of histones and altered chromatin configuration. This can indirectly enhance the activity of EMID2 by influencing the epigenetic environment it interacts with. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Parthenolide inhibits the NF-κB pathway, which is involved in the regulation of immune responses and gene expression. EMID2 could have an enhanced function in the context of modulated gene expression patterns due to NF-κB pathway inhibition. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate (EGCG) can modulate various signaling pathways, including inhibition of histone acetyltransferases, affecting chromatin structure and function. This can enhance the activation of EMID2 by altering the chromatin state. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
MS-275 is a selective histone deacetylase inhibitor that promotes acetylation of histone proteins, altering chromatin architecture and gene expression. This can lead to increased activity of EMID2 through the induced changes in chromatin structure. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA is a histone deacetylase inhibitor that leads to an open chromatin state and altered gene transcription. EMID2 could have increased activation as it functions within the context of chromatin remodeling influenced by SAHA. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
UNC0638 is a selective inhibitor of G9a and GLP histone methyltransferases, leading to reduced histone methylation and changes in chromatin structure. EMID2's activity can be enhanced due to the resulting alterations in the chromatin environment. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 is a DNA methyltransferase inhibitor that prevents DNA methylation, leading to changes in gene expression and chromatin structure. The function of EMID2, which is involved in chromatin organization, may be enhanced as a result of these changes. | ||||||